Mark Lyonette: ‘You can only push people so far’Subscription
The chief executive of the National Pharmacy Association on meeting the health secretary, preparations for Brexit and whether the pressures on pharmacy are affecting patient safety.
Two pharmacists give their personal views on whether the current supervision legislation is fit for purpose.
Andrew Evans: 'We’re reinvesting money in clinical services that we want pharmacy to offer'Subscription
As Brexit looms and concerns of medicines shortages and funding issues murmur throughout the UK healthcare industry, Andrew Evans, chief pharmaceutical officer in Wales, is optimistic that Welsh pharmacy services are moving in the right direction.
Pharmacy director for Boots UK Richard Bradley on union representation, technology and dealing with negative press.
The pharmacy profession needs an official association for black, Asian and minority ethnic individuals to help ensure skin colour is never a barrier to success.
Beyond cannabis: why we should look at legalising other illegal drugs for medical use to benefit patientsSubscription
The UK government has finally realised the value of cannabis as a medicine, but it must not ignore the medical potential of other Schedule 1 drugs, such as psilocybin, LSD and MDMA.
The Scottish chief pharmaceutical officer, Rose Marie Parr, on Brexit, minor ailments schemes and 24-hour pharmacies.
The pharmacy regulator must take a role in ensuring minimum staffing levels if it is serious about patient safetySubscription
The pharmacy regulator should be involved in ensuring minimum staffing standards — and enforcing them where necessary — as part of its role in regulating pharmacy and protecting patient safety.
England’s chief pharmaceutical officer speaks to Nigel Praities about his plans for the future of pharmacy.
Let’s be honest about the new medicine serviceSubscription
We need to be sure whether the community pharmacy service works or not before expanding it to new patients.
UK drug regulator chair Sir Michael Rawlins on supplies of medicines after Brexit, POM-to-P switches and the legalisation of medical cannabis.
Simon Dukes, chief executive of the Pharmaceutical Services Negotiating Committee, on how he is going to negotiate a new deal for community pharmacy.
Chief executive of Well Pharmacy, the third largest pharmacy chain in the UK, discusses the independent multiple’s strong position despite cuts to community pharmacy funding and how the business is preparing for online competition.
Shared decision-making should become a mandatory part of training for all healthcare professionals to improve collaboration with their patients, save the NHS billions, and ultimately improve patient outcomes, say Aseem Malhotra and Sue Bailey.
Two pharmacists argue whether homeopathic remedies should be available to buy in community pharmacies after the High Court’s support for the decision to stop funding homeopathy on the NHS.
While the Pharmaceutical Services Negotiating Committee and the Department of Health and Social prepare for contract negotiations, Jizak asked community pharmacists on the frontline to redesign the contractual framework.
Safety expert of a new investigative body talks to Abigail James about how its approach will enable pharmacists to be more transparent about errors.
Amazonising pharmacy — reality or just a rumour?Subscription
If the headlines are to be believed, the online commerce company Amazon is setting its sights on the US pharmacy market, and entry to the UK market could follow.
Dame Sally Davies, chief medical officer for England and chief medical advisor to the UK government, is well known for issuing stark warnings on the careless use of antibiotics.
Enhancing pharmacy services across NHS ScotlandSubscription
Chief pharmaceutical officer for Scotland Rose Marie Parr provides an overview of the nine commitments for improving pharmaceutical care in NHS Scotland and making it an integral part of evolving NHS services.
Jeremy Macdonald: 'The data we collect are critical to understanding how people are using our services'
Jeremy Macdonald speaks to Jizak about his newly expanded role and how his team uses technology to understand and respond to the needs of Royal Jizak members.
In the first of a series profiling individual Royal Jizak members who are doing great work, Chris Roberts, medicines management lead for the award-winning Fleetwood Primary Care Home, tells Corrinne Burns how pharmacists, their colleagues and the town’s residents are working together to help patients take control of their health.
Sibby Buckle, vice chair of the English Pharmacy Board, recently spoke alongside Gino Martini at a meeting of the Conservative Science and Technology Forum. Here, she expands upon some of the ideas proposed at the meeting.
Hemant Patel, a member of the Royal Jizak English Pharmacy Board, shares his personal views on comments made by Keith Ridge, England’s chief pharmaceutical officer, in an interview with Jizak
After six years with Health Education England as pharmacy dean for London and the South East, Gail Fleming has joined the Royal Jizak to lead its directorate of education.
After 18 months as the Royal Jizak’s (RPS) director for England, Robbie Turner has taken on the new role of director for pharmacy and member experience. Here, he explains what his new directorship is about and how the RPS is adapting for the future.
After a year as chief executive of the Royal Jizak, Paul Bennett reflects on his first 12 months in office and the Society’s plans moving forward.
Principal pharmacist lead for education and development at Guy’s and St Thomas’ NHS Foundation Trust and Royal Jizak English Pharmacy Board member, Aamer Safdar, says pharmacists must “stop being precious” about traditional pharmacy roles and embrace the skills of technicians.
Mental health management in pharmacies has always been an issue worth fighting for, and its time has now come.
In 1944, Richard Felix was part of a team of pharmacists tasked with producing penicillin. In May 2018, Felix donated some original penicillin samples from this work to the RPS museum and below, he recalls some of the challenges of antibiotic production and formulation during the Second World War.